The opportunistic pathogen Pseudomonas aeruginosa expresses a type 3 secretion system (T3SS) strongly associated with bacterial virulence in murine models and human patients. T3SS effectors target host innate immune mechanisms, and T3SS-defective mutants are cleared more efficiently than T3SS-positive bacteria by an immunocompetent host. Nonetheless, T3SS-negative isolates are recovered from many patients with documented P. aeruginosa infections, leading us to test whether T3SS-negative strains could have a selective advantage during in vivo infection. Mice were infected with mixtures of T3SS-positive WT P. aeruginosa plus isogenic T3SS-OFF or constitutively T3SS-ON mutants. Relative fitness of bacteria in this acute pneumonia model was reflected by the competitive index of mutants relative to WT. T3SS-OFF strains outcompeted WT PA103 in vivo, whereas a T3SS-ON mutant showed decreased fitness compared with WT. In vitro growth rates of WT and T3SS-OFF bacteria were determined under T3SS-inducing conditions and did not differ significantly. Increased fitness of T3SS-OFF bacteria was no longer observed at high ratios of T3SS-OFF to WT, a feature characteristic of bacterial cheaters. Cheating by T3SS-OFF bacteria occurred only when T3SS-positive bacteria expressed the phospholipase A 2 effector Exotoxin U (ExoU). T3SS-OFF bacteria showed no fitness advantage in competition experiments carried out in immunodeficient MyD88-knockout mice or in neutrophil-depleted animals. Our findings indicate that T3SS-negative isolates benefit from the public good provided by ExoU-mediated killing of recruited innate immune cells. Whether this transient increase in fitness observed for T3SS-negative strains in mice contributes to the observed persistence of T3SS-negative isolates in humans is of ongoing interest.
T he opportunistic human pathogen Pseudomonas aeruginosa is associated with both acute and chronic pulmonary infections [e.g., acute ventilator-associated pneumonia (VAP) or persistent airways infection in patients with cystic fibrosis (CF)]. Different bacterial traits, or virulence factors, are associated with these two types of infection in humans. Type 3 secretion system (T3SS) expression has been linked to increased risk of P. aeruginosa infection in hospitalized patients (1) and to increased morbidity and mortality in VAP caused by this organism (2) . Initial infections in patients with CF also are associated with T3SS-positive strains (3) . In contrast, T3SS-negative strains are isolated with increasing frequency from chronically infected CF patients over time, and animal models of chronic infection indicate important roles in other virulence traits, such as biofilm formation and quorum-sensing systems (4) .
Several regulatory pathways govern T3SS expression. ExsA, a member of the AraC/XylS family of transcriptional activators, activates its own transcription as well as that of a well-defined set of genes encoding T3SS apparatus proteins, chaperones, and effectors in response to host cell contact or in vitro inducing cues (e.g., calcium limitation) (5, 6) . ExsA activity is controlled by the anti-activator ExsD, which binds and inhibits ExsA when T3SS-inducing cues are absent (7) . ExsD repression is relieved when inducing cues trigger secretion of the T3SS substrate ExsE, thereby freeing its binding partner ExsC to interact with ExsD. Small changes in ExsA, ExsD, ExsC, or ExsE levels lead to large changes in T3SS expression, suggesting that this regulatory cascade may mediate bistable expression of T3SS. Single-cell studies confirm that not all P. aeruginosa bacteria induce expression of T3SS proteins in response to host cell contact or low-calcium cues, resulting in phenotypic heterogeneity within a clonal population (8) (9) (10) .
ExsA is required for expression of T3SS genes; however, additional extrinsic regulators also influence T3SS expression. Among these are a set of two-component signaling proteins (RetS, LadS and GacS/GacA) that regulate T6SS and exopolysaccharide synthetic loci in addition to T3SS operons (11) (12) (13) . Regulation is mediated by changing levels of sRNAs (RsmX, RsmY) that sequester the mRNA binding protein RsmA (14) . RetS deletion leads to a loss of T3SS expression (15) .
Although T3SS expression is strongly correlated with increased P. aeruginosa virulence in murine models and in humans, T3SS-negative bacteria often are isolated from non-CF patients with acute P. aeruginosa infections (1, 2) as well as from chronically colonized CF patients (16) . Therefore we set out to test whether T3SS-negative bacteria might have a competitive advantage in vivo during an acute pulmonary infection. Although WT strains of P. aeruginosa are phenotypically mixtures of T3SS-ON and -OFF bacteria, we also used bacteria with deletions of positive (exsA, retS) and negative (exsD) regulators of T3SS to provide genetically fixed populations of T3SS-OFF and -ON bacteria. All bacteria were isogenic with PA103, a laboratory strain initially isolated from a patient with acute pneumonia (17) .
Significance
Bacterial pathogens frequently use type 3 secretion systems (T3SS) to counteract host immune responses to infection. T3SS expression is associated with increased virulence of Pseudomonas aeruginosa in humans and in animal models, but T3SS-negative bacteria often are isolated from acutely and chronically infected patients. We tested whether T3SS-negative bacteria could "cheat" during mixed infections with T3SS-positive bacteria in a murine model of acute pneumonia. Bacterial cheating occurred in the inflamed lung but only when T3SS-positive bacteria secreted the phospholipase A 2 effector, Exotoxin U. Phenotypically T3SS-expressing and -non-expressing bacteria co-exist within P. aeruginosa populations, suggesting that bacterial cheating might allow T3SS-negative organisms to establish themselves within a host. and ΔexsA, ΔretS, or ΔexsD (unmarked) bacteria were used to inoculate C57BL/6 mice intranasally. Mice were killed at several time points after infection, and the number of gentamicin-sensitive (Gm S ) and Gm R bacteria present in the lung was determined by plating serial dilutions of lung homogenates on Vogel-Bonner medium (VBM) agar plates with and without gentamicin. The ratio of mutant to WT bacteria recovered from the lung was divided by the input ratio of mutant to WT bacteria, resulting in a competitive index (CI) for each animal. The control infection, in which unmarked and marked WT PA103 made up the inoculum, yielded a CI of ∼1 ( Fig. 1 and Fig.  S1 ). In contrast, the CI for infections in which a T3SS-OFF strain competed with WT PA103 was greater than 1, indicating a fitness advantage for the T3SS-negative strain. This advantage also was observed when ΔexsA competed against the T3SS-ON strain ΔexsD. These results were surprising, because the ΔexsA and ΔretS strains are markedly attenuated in mice when used in single-strain infections (Fig. S2) (18) . The T3SS-ON strain, ΔexsD, was at a competitive disadvantage relative to WT PA103.
These experiments were repeated using strain combinations in which mutant bacteria were marked by a chromosomal aacC1 gene and the WT was unmarked. The T3SS-OFF strains continued to exhibit a competitive advantage over WT PA103, indicating that the antibiotic resistance marker was not responsible for the observed phenotypes (Fig. S3) .
In single-strain infections, T3SS-positive P. aeruginosa elicit innate immune responses more quickly than T3SS-negative bacteria (19) . This faster response is a consequence of inflammasomemediated recognition of the T3SS (20, 21) and results in a relative delay in T3SS-negative bacterial clearance in single-strain infections (19) . We therefore examined the innate immune response of mice infected with mixtures of T3SS-positive and -negative bacteria. Airway inflammation was assessed by measuring immune cell recruitment and cytokine levels in bronchoalveolar lavage (BAL) fluid. Neutrophil recruitment and chemokine (C-X-C motif) ligand 1 [CXCL1, also called keratinocyte chemoattractant (KC)] production were similar in animals infected with WT/WT bacteria and those infected with mutant/WT mixtures (Fig. S4) , confirming that the presence of mutant bacteria did not alter the expected proinflammatory host response to WT PA103 infection (19, 22) .
Growth rates for WT and ΔexsA bacteria were determined in defined MinS medium in the presence of the chelator nitrilotriacetic acid (23), i.e., under T3SS-inducing conditions. The specific growth rate (μ max ) of PA103 under these conditions was 0.560 ± 0.007/h, which was indistinguishable from that measured for ΔexsA, 0.549 ± 0.058/h. Thus, no in vitro difference in growth rates easily accounts for our in vivo observations. Under these conditions, ca. 80% of WT bacteria express T3SS proteins, as assessed by the use of a P exoU -sfGFP reporter (Fig. S5 ).
T3SS-OFF Bacteria Exhibit Behavior Suggestive of Cheating. The production of a public good by members of a population can be exploited by cheaters that take advantage of the good without incurring costs associated with its production (24) . Such populations become unstable when the number of cheaters becomes excessive. We tested whether ΔexsA bacteria continued to exhibit a CI >1 when they were inoculated into mice at ratios of 10:1 or 1:10 relative to WT PA103. Although the CI for ΔexsA was almost 10 when WT bacteria outnumbered the mutant in the starting inoculum, inoculation of an excess of ΔexsA relative to WT resulted in a CI <1 ( Fig. 2 and Fig. S6 ). The control experiment, in which marked and unmarked WT PA103 were mixed in a 10:1 ratio, yielded a CI of ca. 1. Thus, the increased fitness of ΔexsA bacteria depends on the continued presence of some proportion of WT PA103.
A very similar observation was made when mice that had been inoculated with a 1:1 mixture of mutant and WT bacteria were examined at later time points. At 12 h postinfection (hpi), ΔexsA bacteria significantly outnumbered WT PA103, but by 20 hpi the ΔexsA population "collapsed," again suggesting that persistence of ΔexsA bacteria in the mixed infections requires the presence of WT PA103 above a certain threshold (Fig. 3 and Fig. S7A ). Total bacteria in the lung decreased with time over the course of infection, as is expected in WT animals infected with this low bacterial inoculum (22) , but mice infected with ΔexsA:WT had a greater bacterial burden than other groups at 12 hpi (Fig. S7B) . Neutrophil recruitment to the airways did not differ significantly among groups of mice (Fig. S7C) .
Expression of the T3SS Effector Exotoxin U is Necessary to Observe
Cheating by a T3SS-OFF Mutant. WT PA103 translocates two of the four known P. aeruginosa exotoxins via its T3SS, Exotoxin U (ExoU) (a phospholipase A 2 ) and ExoT [a bifunctional ADP ribosyl transferase/GTPase-activating protein (ADPRT/GAP)]. Only 15-20% of P. aeruginosa isolates carry the exoU gene; the remainder encodes a second ADPRT/GAP, ExoS, which targets a different set of host cell proteins than ExoT (25) . Isogenic strains that express only ExoU (ΔexoT) or ExoT (ΔexoU), as well as a strain engineered to express ExoS from its native promoter in the absence of other effectors (ΔexoU exoT attB::exoS) were tested for their ability to support ΔexsA cheating. ΔexsA bacteria showed no competitive advantage in mixed infections with T3SS-positive bacteria lacking ExoU but had a CI >1 when mixed with a strain in which ExoU is the only T3SS effector produced (Fig. 4 and Fig.  S8 ). Thus, translocation of ExoU by T3SS-positive bacteria is both necessary and sufficient for ΔexsA to gain a competitive advantage in mixed infections (CI >1).
T3SS-OFF Cheating Is Not Seen in a Host with Impaired Innate Immune
Responses. The observation that ExoU is required to permit ΔexsA cheating suggested that an activity of ExoU benefits both WT and ΔexsA bacteria. ExoU is a phospholipase A 2 enzyme that causes rapid necrosis of multiple cell types (26, 27) . Thus, ExoU Indicated strains were mixed in a 1:1 ratio and inoculated intranasally into C57BL/6 mice. Animals were killed at 4 hpi, and serial dilutions of single-cell lung resuspensions were plated to VBM and VBM plus gentamicin to determine numbers of WT and mutant bacteria present in the lung. The CI ([mut out /wt out ]/[mut in /wt in ]) is plotted for each animal; horizontal lines indicate the geometric mean for each group. ANOVA followed by Dunnett's multiple comparison test was carried out on log-transformed data; all groups vary significantly from the control (WT:WT). **P < 0.01; ***P < 0.001. translocation may benefit producer and bystander bacteria by releasing host cell-derived compounds that favor bacterial growth or survival in the host environment. ExoU also plays an early and important role in combating neutrophil-mediated bacterial killing during infection (28) . We tried to distinguish between these two possibilities by repeating our competition experiments in MyD88-deficient mice, in which neutrophil recruitment is significantly delayed and attenuated (Fig. S9) (22) . ΔexsA bacteria exhibited no fitness advantage in the absence of an immune response, supporting the idea that the public good provided by ExoU is attenuation of host immune responses (Fig. 5 and Fig. S10) . A central role for neutrophils in this selective host response was demonstrated by pretreating animals with the anti-Gr-1 mAb (RB6-8C5), which depletes Ly6G/Ly6C-expressing cells such as neutrophils and Gr-1 + monocytes. We used 1:1 mixtures of WT and ΔexsA (marked) bacteria to infect mice treated with anti-Gr-1. ΔexsA bacteria again showed no fitness advantage (CI <1) in the setting of diminished neutrophil recruitment to the airways (Fig. 6 and Fig. S11 ).
Discussion
Type 3 secretion is strongly associated with virulence in animal models of acute infection and in patients with non-CF-associated P. aeruginosa infections. Nonetheless, T3SS-negative strains are isolated from a significant proportion of individuals with clinically significant acute infections in which no other pathogen is implicated (1, 2). This observation prompted us to ask whether there are circumstances under which T3SS-negative bacteria might have a competitive advantage over T3SS-positive counterparts in vivo. Competition experiments between WT T3SS-positive P. aeruginosa and isogenic mutants unable to express T3SS components or mutants that constitutively express the T3SS demonstrated that T3SS-negative bacteria can outcompete T3SS-positive organisms in a murine model of acute pneumonia. The outcome of such competitions was sensitive to the input ratio of the two strains and was not observed when the T3SS-negative strain was inoculated in 10-fold excess over the WT strain. This behavior is characteristic of bacterial cheaters, because individuals that benefit from a public good without incurring the costs of its production (i.e., cheaters) show highest fitness when they are less numerous (29) .
The public good provided by WT bacteria was associated with the production of a specific T3SS effector, ExoU. This bacterial phospholipase A 2 causes rapid cell necrosis and plays a significant role in vivo in killing neutrophils recruited to the lung in response to infection. Because neutrophils appear to provide the main defense against P. aeruginosa in murine infection models, ExoU production strongly influences bacterial clearance (28) . Neutrophil killing by ExoU-producing P. aeruginosa can even lead to local immunosuppression, as shown by the ability of an ExoU-positive strain to promote survival of avirulent Escherichia coli XL1-Blue during a mixed pulmonary infection (30) . ExoU exerts its effect early in infection, because even a 3-h delay in ExoU expression is associated with improved bacterial clearance during murine pneumonia and increased animal survival (28) .
Cheating by T3SS-negative bacteria was not observed during infections of MyD88 −/− mice. These animals, which are deficient in IL-1 receptor and most Toll-like receptor signaling pathways, fail to mount the typical innate immune response to P. aeruginosa infection, i.e., rapid recruitment of neutrophils to the airways and lung (22) . Likewise, T3SS-negative bacteria exhibited no fitness advantage during infections of mice pretreated with the neutrophil-depleting anti-Gr-1 mAb. These findings are consistent with a model in which neutrophil killing is the public good associated with ExoU secretion. Lysis of neutrophils would benefit T3SS-positive and -negative bacteria alike by limiting both phagocytosis and neutrophil bactericidal activities such as production of reactive oxygen species, degranulation, release of antimicrobial peptides, and formation of neutrophil extracellular traps. Very early in infection, T3SS-producing bacteria outnumber neutrophils recruited to the airways; ExoU-mediated killing of these immune cells allows bacteria time to replicate in the lung (30) . T3SS-negative bacteria appear to enjoy a relative growth advantage in vivo over their T3SS-producing counterparts (Figs. S6 and S7) that likely affords them the competitive advantage that we observe early in infection. Neutrophils continue to be recruited to the lung, however, and eventually outnumber bacteria in our C57/Bl6 model. At this point, T3SS-negative bacteria would be expected to be at a disadvantage relative to T3SS-producing counterparts that can functionally impair or kill the neutrophils with which they interact and to be cleared more efficiently from the lung, as we observe.
ExoU-negative bacteria engineered to express two other T3SS effectors, ExoT and ExoS, were not outcompeted by T3SS-negative organisms in our experiments. These bifunctional Rho-GAP/ ADPRT effectors inhibit bacterial uptake by professional phagocytes. Although these effectors could fulfill the function of Fig. 2 . ΔexsA bacteria show decreased fitness when present in excess over WT PA103. WT and ΔexsA bacteria were mixed in 1:10 ratios as indicated and then were inoculated intranasally into C57BL/6 mice. Animals were euthanized at 4 hpi, and the CI in the lung was determined for each animal as described previously. Each symbol represents an individual animal; horizontal lines indicate geometric means for each group. ANOVA followed by Dunnett's multiple comparison test was performed on log-transformed data. *P < 0.5; ***P < 0.001. Fig. 3 . T3SS-OFF bacteria bloom and then collapse over the course of an 18-h infection. Indicated bacterial strains were inoculated intranasally into C57BL/6 mice in a 1:1 ratio. Animals were killed at the indicated times, and bacterial numbers in the lung were determined as previously described. Each symbol represents the CI for an individual animal; horizontal lines indicate the geometric mean for each group. ANOVA followed by Dunnett's multiple comparison test was performed on log-transformed data; mutant:WT groups were compared with the WT:WT control at each time point. *P < 0.5; **P < 0.01; ***P < 0.001. a public good if they prevented uptake of T3SS-negtive bacteria in trans, they appear not to do so during in vivo infection. This lack of effect likely results, at least in part, from the low probability (which we estimate to be <1) of two bacteria interacting with the same resident or recruited phagocyte at the effective multiplicity of infection achieved in the murine airway. The inability of T3SS-negative bacteria to avoid phagocytosis is likely to be responsible for their diminished fitness relative to ExoT-and ExoS-producing bacteria.
Elegant work from Hardt and colleagues has recently examined how bistable T3SS-1 expression in Salmonella enterica sv. Typhimurium prevents the within-host evolution of avirulent t3ss-1 mutants (31). Such avirulent mutants, which these authors (31) call "defectors," benefit from the inflammation caused by T3SS-1-expressing bacteria, which suppresses the growth of gut commensals, and enjoy a growth advantage over the T3SS-1-expressing "cooperators." However, the outgrowth of these genetically t3ss-1-negative defectors in the infected host is followed by decreased inflammation and decreased numbers of S. typhimurium in the mouse gut. Because phenotypically T3SS-1-negative members of the genetically WT population enjoy the same growth advantage as avirulent defectors but stochastically give rise to T3SS-1-expressing progeny, they appear to delay the appearance of defectors and allow genetically WT T3SS-1 to persist in the gut.
Why do we observe increased fitness of ΔexsA bacteria in competitions with WT PA103? Observations from the Salmonella system suggest that there is a cost to producing T3SS components and effectors, but the growth rates measured in vitro in T3SS-inducing MinS medium did not differ appreciably between WT and ΔexsA bacteria. However, this in vitro condition may be a poor mimic of conditions experienced in the infected lung. The fact that we do not observe a fitness advantage for ΔexsA in all competition settings argues against an unconditional in vivo growth advantage accounting for our findings. Rather, ΔexsA bacteria exploit the relative immunosuppression that follows ExoU translocation and show no fitness advantage when the host's innate immune response is attenuated. ExoU functions as a public good in this system, but ExoS and ExoT behave as private goods whose production selects for the maintenance of T3SS-positive bacteria by preventing their phagocytosis by resident alveolar macrophages or recruited neutrophils.
Immunocompetent mice infected with P. aeruginosa strains either will clear the infection or will succumb if challenged with a sufficiently large inoculum; a chronic pulmonary infection state is not established unless the inoculum is encapsulated within a matrix (e.g., agar beads) that prevents bacterial clearance. Thus, we cannot test whether the transient bloom that we observe in T3SS-OFF bacteria allows them to reach and colonize additional areas within the respiratory tract where they subsequently can persist in the absence of a strong proinflammatory response. In such a model of pathogenesis, we would expect the establishment of spatial heterogeneity within the lung, with regards to both inflammation and the distribution of T3SS-OFF versus T3SS-ON bacteria. Interestingly, nonhomogeneity of inflammation has long been observed in the setting of CF, as assessed both by radiologic imaging and by regional BAL of chronically infected patients (32, 33) . Recent studies examining explanted lungs of CF patients undergoing lung transplantation have shown that bacterial distribution within the lungs also is spatially heterogeneous (34), a pattern likewise seen for viral DNA (35) . Such studies provide the opportunity to test whether spatially distinct populations of a specific CF pathogen, such as P. aeruginosa, show genetic and phenotypic heterogeneity in features such as T3SS expression (36), a possibility suggested by the coisolation of T3SS-positive and -negative P. aeruginosa from the sputum of CF patients (16) .
ExoU-secreting P. aeruginosa strains make up a small but stable percentage (15-20%) of T3SS-positive isolates in surveys of environmental and clinical isolates (25, 37, 38) . It is unlikely that this distribution of isolates is maintained by selection in the mammalian host. However, it is interesting to speculate that the presence of ExoU-producing strains in environmental reservoirs might be maintained because of this effector's ability to kill amoebal predators of P. aeruginosa (39, 40) , thus providing a public good for ExoU-negative organisms. Fig. 4 . Increased fitness of ΔexsA is observed only during mixed infections with ExoU-producing bacteria. Indicated bacterial strains were inoculated intranasally into C57BL/6 mice in a 1:1 ratio. Animals were killed at 4 hpi, and bacterial numbers in the lung were determined as previously described. Each symbol represents the CI for an individual animal; horizontal lines indicate the geometric mean for each group. ANOVA followed by Dunnett's multiple comparison test was performed on log-transformed data, and each mixed ΔexsA infection was compared with the ΔexsA:WT control. ***P < 0.001. −/− mice in a 1:1 ratio. Animals were killed at the indicated times, and bacterial numbers in the lung were determined as previously described. Each symbol represents the CI for an individual animal; horizontal lines indicate the geometric mean for each group. ANOVA followed by Dunnett's multiple comparison test was performed on log-transformed data; mutant:WT groups were compared with the WT:WT control at each time point. *P < 0.5; **P < 0.01.
Materials and Methods
Bacterial Strains. PA103 (17) and the isogenic unmarked deletion mutants exsA (41), exsD (42), and retS (rtsM) (15) have been described previously. The P exoU -superfolder GFP (sfGFP) reporter was constructed by PCR amplifying sfGFP from plasmid pTB263 (43) with primers sfGFP-F (5′ GAGACCCGGGA-GGAGGTGAGAATGTCTAAAGGTGAAGAACTGTTC-3′, restriction site underlined) and sfGFP-R (5′ GAGA CTCGAGACTTATTAGGATCCGCCAG-3′). The resulting ribosome-binding site-coding sequence cassette was digested with XmaI and XhoI and was subcloned into pBluescript-II. The exoU promoter region (44) was PCR amplified from PA103 genomic DNA with primers exoU-F (5′ GAGCGGCCGCAGGCGATCCGCACCGA -3′) and exoU-R (5′ CACCCGGGA-AATACCGAGGGTTCGGAGCAA-3′). The resulting amplicon was digested with NotI and XmaI and then was subcloned upstream of the sfGFP coding sequence. The P exoU -sfGFP cassette was moved from pBluescript to mini-CTX2 as a NotI-KpnI fragment, allowing it to be integrated into the P. aeruginosa chromosome at the attB site. Vector backbone sequences were excised as previously described (45) . Bacteria were maintained at −80°C as 15% (vol/vol) glycerol stocks and were freshly plated to VBM or LB agar [supplemented with gentamicin (100 μg/mL) as appropriate].
Mice. All animal work was conducted according to relevant national and international guidelines. Protocols for all animal studies were approved by the Yale Institutional Animal Care and Use Committee. Mice were housed in isolator cages under specific pathogen-free conditions. MyD88 −/− (N9) mice on a C57BL/6 background have been described (46) . C57BL/6 animals were purchased from the National Cancer Institute (National Institutes of Health).
Mouse Infections. Groups of 8-to 10-wk-old sex-matched mice were infected intranasally with ca. 1 × 10 5 cfu of early log-phase bacteria as described previously (19, 22) . Mice were killed 4, 12, or 18-20 hpi. BAL fluid was collected and processed for cytokine assays and differential counts as previously described (19, 22) . Lungs were aseptically removed, weighed, homogenized in PBS, and passed through a sterile screen to obtain single-cell suspensions. Samples were serially diluted and plated on VBM agar without or with gentamicin (100 μg/mL). Colonies were counted after incubation for 36 h at 37°C.
Neutrophil Depletion. Circulating neutrophils in mice were depleted using mouse mAb Gr-1 (clone RB6-8C5) (47) , kindly provided by Charles Brown (University of Missouri, Columbia, MO) and Ruth Montgomery (Yale University, New Haven, CT). RB6-8C5 cells were cultured in DMEM with 10% (vol/vol) FBS, 10 mM Hepes, 2 mM L-glutamine, and antibiotics. RB6-8C5 antibody was affinity purified from cell-culture supernatants using a protein G column (Pharmacia). The 8-to 10-wk-old mice were injected i.p. with 250 μg of RB6-8C5 in 200 μL of PBS 1 d before infection with P. aeruginosa.
Growth Curves, Flow Cytometry, and Fluorescence Microscopy. Single bacterial colonies were inoculated into LB, were grown overnight with aeration at 37°C, and then were subcultured into MinS medium for induction of T3SS expression (48) . Growth rates were determined as described (49) . Culture aliquots were sampled at 12-24 h postinduction, fixed with 1% paraformaldehyde for 10 min at 4°C, and washed with PBS. GFP emission was analyzed at 530 nm using a BD LSRII flow cytometer (BD Biosciences). Bacteria were identified by side scatter. At least 70,000 events were analyzed by FlowJo (v. 9.7.1) software to determine P exoU -sfGFP expression in samples. GFP-positive and -negative gates were set using exsA, so that the mean fluorescence intensity of events scored as GFP-positive exceeded that observed for 99% of exsA bacteria. Bacteria also were visualized by phase-contrast and fluorescence microscopy after 24 h of subculture in MinS medium. Fluorescence intensity measurements were determined using ImageJ (National Institutes of Health) from overlays of phase-contrast and GFP images, in the GFP channel, and were normalized by subtracting the average background fluorescence for each field.
Measurement of Cytokines. KC levels in BAL fluid were measured by sandwich ELISA (R&D Systems) according to the manufacturer's protocol.
Statistical Analysis. Data were analyzed in GraphPad Prism (v. 5.0). One-way ANOVA followed by Dunnett's multiple comparison posttest was used to compare log-transformed data. P values <0.5 were considered statistically significant.
A B Fig. 6 . T3SS-OFF bacteria have no competitive advantage over T3SS-ON strains in the absence of neutrophil recruitment. Anti-Gr-1 mAb was administered i.p. to mice 24 h before infection. Indicated bacterial strains were inoculated intranasally into mice in a 1:1 ratio. Animals were killed at 4 hpi, and bacterial numbers in the lung were determined as previously described. (A) Each symbol represents the CI for an individual animal; horizontal lines indicate the geometric mean for each group. A two-tailed t test was performed on log-transformed data. ***P < 0.0001. (B) Bacterial recovery from lung of coinfected strains. Horizontal lines indicate the median for each group.
